U.S. Congress. House. Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. H. Res. 1285. 119th
Cong., 2nd
sess., Introduced in House May 14, 2026. https://www.govinfo.gov/app/details/BILLS-119hres1285ih.
Congress, House of Representatives (2026, May 14). Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. (H. Res. 1285 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hres1285ih.
United States, Congress, House of Representatives. Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hres1285ih. 119th Congress, H. Res. 1285, Introduced in House 14 May. 2026.
H.Res.1285 – 119th Congress (2025-2026): Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science., H.Res.1285, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hres1285ih.